Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ABBV

AbbVie

$93.14

0.535 (0.58%)

, ACOR

Acorda Therapeutics

$23.30

-0.1 (-0.43%)

04:55
04/24/18
04/24
04:55
04/24/18
04:55
Conference/Events
American Academy of Neurology to hold annual meeting »

2018 Annual Meeting of…

ABBV

AbbVie

$93.14

0.535 (0.58%)

ACOR

Acorda Therapeutics

$23.30

-0.1 (-0.43%)

ALXN

Alexion

$107.73

-0.11 (-0.10%)

AKCA

Akcea Therapeutics

$27.78

1.77 (6.81%)

RHHBY

Roche

TEVA

Teva

$17.85

0.035 (0.20%)

UBS

UBS

$17.12

-0.535 (-3.03%)

MDT

Medtronic

$80.04

0.145 (0.18%)

MCK

McKesson

$148.29

2.005 (1.37%)

NVTA

Invitae

$5.58

-0.125 (-2.19%)

IONS

Ionis Pharmaceuticals

$50.74

2.29 (4.73%)

IPXL

Impax

$19.65

-0.25 (-1.26%)

DNA

Bought by RHHBY

DGX

Quest Diagnostics

$99.45

1.26 (1.28%)

ESALY

Eisai

DEPO

Depomed

$6.78

0.1 (1.50%)

CPRX

Catalyst Pharmaceuticals

BSX

Boston Scientific

$28.82

-0.01 (-0.03%)

BMRN

BioMarin

$82.09

-0.2 (-0.24%)

MYL

Mylan

$40.77

0.04 (0.10%)

NBIX

Neurocrine

$81.37

2 (2.52%)

NVS

Novartis

$77.60

-0.255 (-0.33%)

PFE

Pfizer

$36.80

0.165 (0.45%)

RARX

RA Pharmaceuticals

$6.04

-0.25 (-3.97%)

SNY

Sanofi

SYK

Stryker

$166.80

2.53 (1.54%)

SUPN

Supernus

$47.50

-1.05 (-2.16%)

LLY

Eli Lilly

$80.25

1.16 (1.47%)

BAYRY

Bayer

AMGN

Amgen

$174.66

3.19 (1.86%)

ALNY

Alnylam

$95.77

-1.58 (-1.62%)

BIIB

Biogen

$259.30

-3.61 (-1.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

  • 27

    Apr

  • 28

    Apr

  • 30

    Apr

  • 30

    Apr

  • 01

    May

  • 02

    May

  • 02

    May

  • 03

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 10

    May

  • 17

    May

  • 18

    May

  • 21

    May

  • 22

    May

  • 23

    May

  • 23

    May

  • 25

    May

  • 28

    May

  • 30

    May

  • 05

    Jun

  • 07

    Jun

  • 07

    Jun

  • 12

    Jun

  • 12

    Jun

  • 16

    Jun

  • 06

    Jul

  • 11

    Aug

  • 12

    Sep

  • 05

    Oct

  • 20

    Oct

  • 13

    Nov

Monday
ABBV

AbbVie

$92.61

-0.395 (-0.42%)

, ACOR

Acorda Therapeutics

07:07
04/23/18
04/23
07:07
04/23/18
07:07
Conference/Events
American Academy of Neurology to hold annual meeting »

2018 Annual Meeting of…

ABBV

AbbVie

$92.61

-0.395 (-0.42%)

ACOR

Acorda Therapeutics

ALXN

Alexion

$107.84

-3.9 (-3.49%)

AKCA

Akcea Therapeutics

$26.01

1.96 (8.15%)

RHHBY

Roche

TEVA

Teva

$17.81

0.11 (0.62%)

UBS

UBS

$17.66

-0.005 (-0.03%)

MDT

Medtronic

$79.89

-0.11 (-0.14%)

MCK

McKesson

$146.28

-0.81 (-0.55%)

NVTA

Invitae

$5.71

-0.075 (-1.30%)

IONS

Ionis Pharmaceuticals

$48.45

2.6 (5.67%)

IPXL

Impax

$19.90

-0.3 (-1.49%)

DNA

Bought by RHHBY

DGX

Quest Diagnostics

$98.19

-3.31 (-3.26%)

ESALY

Eisai

DEPO

Depomed

$6.68

-0.11 (-1.62%)

CPRX

Catalyst Pharmaceuticals

$2.52

-0.01 (-0.40%)

BSX

Boston Scientific

$28.83

-0.05 (-0.17%)

BMRN

BioMarin

$82.29

-1.31 (-1.57%)

MYL

Mylan

$40.73

-0.08 (-0.20%)

NBIX

Neurocrine

$79.37

1.23 (1.57%)

NVS

Novartis

$77.85

-1.14 (-1.44%)

PFE

Pfizer

$36.63

0.1 (0.27%)

RARX

RA Pharmaceuticals

$6.29

0.08 (1.29%)

SNY

Sanofi

$39.96

-0.2 (-0.50%)

SYK

Stryker

$164.27

0.72 (0.44%)

SUPN

Supernus

$48.55

-0.3 (-0.61%)

LLY

Eli Lilly

$79.09

-0.64 (-0.80%)

BAYRY

Bayer

AMGN

Amgen

$171.47

-1.38 (-0.80%)

ALNY

Alnylam

$97.35

1.33 (1.39%)

BIIB

Biogen

$262.91

-3.1 (-1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

  • 28

    Apr

  • 30

    Apr

  • 01

    May

  • 02

    May

  • 02

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 10

    May

  • 17

    May

  • 18

    May

  • 21

    May

  • 22

    May

  • 23

    May

  • 23

    May

  • 25

    May

  • 28

    May

  • 30

    May

  • 05

    Jun

  • 07

    Jun

  • 07

    Jun

  • 12

    Jun

  • 12

    Jun

  • 16

    Jun

  • 06

    Jul

  • 11

    Aug

  • 12

    Sep

  • 05

    Oct

  • 20

    Oct

  • 13

    Nov

Over a week ago
IONS

Ionis Pharmaceuticals

$43.62

-0.2 (-0.46%)

, AKCA

Akcea Therapeutics

$23.18

-0.79 (-3.30%)

09:25
04/16/18
04/16
09:25
04/16/18
09:25
Conference/Events
Akcea Therapeutics to host special shareholder meeting »

Special Shareholder…

IONS

Ionis Pharmaceuticals

$43.62

-0.2 (-0.46%)

AKCA

Akcea Therapeutics

$23.18

-0.79 (-3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 26

    Apr

  • 10

    May

  • 23

    May

  • 06

    Jul

IONS

Ionis Pharmaceuticals

$43.62

-0.2 (-0.46%)

, AKCA

Akcea Therapeutics

$23.18

-0.79 (-3.30%)

04:55
04/16/18
04/16
04:55
04/16/18
04:55
Conference/Events
Akcea Therapeutics to host special shareholder meeting »

Special Shareholder…

IONS

Ionis Pharmaceuticals

$43.62

-0.2 (-0.46%)

AKCA

Akcea Therapeutics

$23.18

-0.79 (-3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 26

    Apr

  • 10

    May

  • 23

    May

  • 06

    Jul

IONS

Ionis Pharmaceuticals

$43.62

-0.2 (-0.46%)

, AKCA

Akcea Therapeutics

$23.18

-0.79 (-3.30%)

16:07
04/15/18
04/15
16:07
04/15/18
16:07
Conference/Events
Akcea Therapeutics to host special shareholder meeting »

Special Shareholder…

IONS

Ionis Pharmaceuticals

$43.62

-0.2 (-0.46%)

AKCA

Akcea Therapeutics

$23.18

-0.79 (-3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 10

    May

  • 23

    May

  • 06

    Jul

IONS

Ionis Pharmaceuticals

$47.74

-3.04 (-5.99%)

, AKCA

Akcea Therapeutics

$32.00

-0.44 (-1.36%)

07:04
03/26/18
03/26
07:04
03/26/18
07:04
Hot Stocks
Ionis, Akcea Therapeutics present data from ATTR amyloidosis program »

Ionis Pharmaceuticals…

IONS

Ionis Pharmaceuticals

$47.74

-3.04 (-5.99%)

AKCA

Akcea Therapeutics

$32.00

-0.44 (-1.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 26

    Apr

  • 10

    May

  • 23

    May

  • 06

    Jul

Over a month ago
ANET

Arista Networks

$281.85

-11.87 (-4.04%)

, GRUB

GrubHub

$109.08

-1.45 (-1.31%)

10:31
03/19/18
03/19
10:31
03/19/18
10:31
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

ANET

Arista Networks

$281.85

-11.87 (-4.04%)

GRUB

GrubHub

$109.08

-1.45 (-1.31%)

AKCA

Akcea Therapeutics

$31.21

3.07 (10.91%)

ZTS

Zoetis

$84.17

-0.4288 (-0.51%)

SPH

Suburban Propane

$23.08

-0.7201 (-3.03%)

APU

AmeriGas

$40.82

-1.26 (-2.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

  • 29

    Mar

  • 26

    Apr

  • 10

    May

  • 29

    May

  • 07

    Jun

  • 11

    Jun

AKCA

Akcea Therapeutics

$31.21

3.07 (10.91%)

06:00
03/19/18
03/19
06:00
03/19/18
06:00
Downgrade
Akcea Therapeutics rating change at Wells Fargo »

Akcea Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 10

    May

AKCA

Akcea Therapeutics

$28.14

7.8 (38.35%)

, IONS

Ionis Pharmaceuticals

$52.18

-1.39 (-2.59%)

08:12
03/16/18
03/16
08:12
03/16/18
08:12
Recommendations
Akcea Therapeutics, Ionis Pharmaceuticals analyst commentary at Stifel »

Inotersen licensing deal…

AKCA

Akcea Therapeutics

$28.14

7.8 (38.35%)

IONS

Ionis Pharmaceuticals

$52.18

-1.39 (-2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 10

    May

  • 06

    Jul

ALXN

Alexion

$126.83

4.15 (3.38%)

, DG

Dollar General

$93.44

4.24 (4.75%)

16:25
03/15/18
03/15
16:25
03/15/18
16:25
General news
On The Fly: Top stock stories for Thursday »

The market opened with…

ALXN

Alexion

$126.83

4.15 (3.38%)

DG

Dollar General

$93.44

4.24 (4.75%)

HAS

Hasbro

$88.15

-0.38 (-0.43%)

MAT

Mattel

$13.84

-0.34 (-2.40%)

CME

CME Group

$165.39

2.44 (1.50%)

ENB

Enbridge

$31.46

-1.63 (-4.93%)

TRP

TransCanada

$42.82

-1.28 (-2.90%)

WMB

Williams

$26.69

-1.45 (-5.15%)

ETP

Energy Transfer Partners

$16.61

-1.11 (-6.26%)

KMI

Kinder Morgan

$16.31

-0.11 (-0.67%)

EPD

Enterprise Products

$24.94

-0.69 (-2.69%)

AKCA

Akcea Therapeutics

$28.14

7.8 (38.35%)

IONS

Ionis Pharmaceuticals

$52.18

-1.39 (-2.59%)

DDD

3D Systems

$12.86

0.71 (5.84%)

QRVO

Qorvo

$79.00

-3.22 (-3.92%)

SNAP

Snap

$17.20

-0.65 (-3.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Mar

  • 15

    Mar

  • 15

    Mar

  • 15

    Mar

  • 28

    Mar

  • 03

    Apr

  • 03

    Apr

  • 05

    Apr

  • 26

    Apr

  • 10

    May

  • 06

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.